Company News
Biohaven Downgraded, Target Cut to $19
Biohaven shares fell 4.2% after RBC Capital lowered its rating from Outperform to Sector Perform.
RBC cut the price target to $19 from $23, citing the stock’s roughly 100% gain earlier this year.
Anal
